Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dosage and administration of anti-C5 antibodies for treatment of protein-losing enteropathy in patients

Dosage and administration of anti-C5 antibodies for treatment of protein-losing enteropathy in patients

US Patent 11459382 · Granted Oct 4, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treatment of refractory generalized myasthenia gravis2025
Atypical hemolytic uremic syndrome (AHUS) biomarker proteins2024
Methods of treating myointimal proliferation2022
Risk evaluation and management strategy involving patient follow-ups relating to2022
Reagents and methods for detecting PNH type II white blood cells and their ident2021
Risk evaluation and management strategy involving patient follow-ups relating to2021
Reagents and methods for detecting PNH type II white blood cells and their ident2018
Methods for treating complement-associated disorders2017
Atypical hemolytic uremic syndrome (aHUS) biomarker proteins2017
Atypical hemolytic uremic syndrome (AHUS) biomarker proteins2016
Methods and compositions for treating complement-associated disorders2016
Method of using IL-11 for treating mucositis2005